MedTrace Logo

Revitalize Cognition: Near Infrared Stimulation in Older Adults

NCT02582593 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-02-19

Study results available
· View outcomes & findings →

Summary

Changes in mood and cognition are common in older adulthood. Some studies have suggested that transcranial application of near-infrared (NIR) light may have enhancing effects on cognitive and mood status in young adults and individuals with traumatic brain injury. This effect has not been examined in older adults. This study will involve a randomized sham-controlled trial to learn whether NIR stimulation improves cognition and mood in older adults, relative to sham treated controls.

Aim 4 of this study (Parkinson Specific) is registered separately under NCT06688357

Conditions

  • Aging

Interventions

DEVICE

MedX 1116 Rehab Console

This intervention makes use of transcranially applied near infrared light using light emitting diodes. Near infrared light will be applied to the scalp for a period of 1 hour at each session. A total of six session will be held.

DEVICE

Sham MedX 1116 Rehab Console

This intervention makes use of sham transcranially applied near infrared light using light emitting diodes. Light emitting diodes (but not near-infrared light) will be applied to the scalp for a period of 1 hour at each session. A total of six session will be held.

Sponsors & Collaborators

  • Ed and Ethel Moore Alzheimer's Disease Research Program

    collaborator UNKNOWN

  • University of Florida

    lead OTHER

Principal Investigators

  • Dawn Bowers, Ph.D. · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
62 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-18
Primary Completion
2023-11-17
Completion
2023-11-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02582593 on ClinicalTrials.gov